Using Brain Imaging to Predict Success with Anxiety Management Apps

New research shows brain imaging can help identify young adults who will benefit most from digital anxiety management tools, paving the way for personalized mental health care.
Recent research indicates that brain imaging can help identify individuals who are most likely to benefit from digital anxiety interventions. A new analysis from a clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian reveals that variations in brain connectivity, particularly in regions involved in emotion regulation and response to anxiety-provoking stimuli, can predict how well young adults will respond to a self-guided anxiety management app called Maya.
The study focused on young adults aged 18 to 25 dealing with anxiety. Participants underwent brain MRI scans before using the Maya app, which is based on cognitive behavioral therapy principles. The app offers interactive modules, videos, exercises, and educational content designed to teach users skills to manage anxiety and alter their thought patterns.
Initial clinical trial results showed that many participants experienced a reduction in anxiety symptoms after six weeks of app use, with some maintaining these benefits even after discontinuation. Building on this, the new analysis demonstrated that those with weaker neural connections between brain areas responsible for attending to and regulating emotional responses were more likely to experience significant improvement.
These findings suggest that the brain’s functional patterns, particularly less efficient regulation in certain networks, may make individuals more receptive to app-based interventions. Conversely, participants with stronger connectivity in circuits related to heightened attention to threats were less likely to benefit.
Dr. Faith Gunning, senior author and associate professor of psychology at Weill Cornell, explained that cognitive behavioral therapy helps individuals learn to better control their emotional responses, which aligns with why those with specific brain patterns respond more favorably.
The Maya app was developed to bridge gaps in mental health care access, especially among young adults who often face barriers such as stigma, cost, or limited healthcare coverage. Participants used the app twice weekly for six weeks, and outcomes were monitored over 12 weeks. Overall, users showed sustained anxiety reduction, indicating its potential as a scalable treatment option.
This research highlights the potential of combining neuroimaging with digital therapy approaches to personalize mental health treatment, ultimately allowing clinicians to recommend the most effective interventions based on individual brain profiles. Such advancements could enhance early intervention strategies and improve outcomes for young adults struggling with anxiety.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Using Medication Switching as a Measure of Antidepressant Treatment Response
New research shows that tracking medication switching can be a valuable tool for assessing antidepressant treatment response and understanding non-response factors, paving the way for personalized mental health treatments.
Oxytocin Might Help Alleviate Mood Fluctuations in Women Experiencing Sleep Disruption
Emerging research suggests that oxytocin may help reduce mood fluctuations in women experiencing sleep disturbances during reproductive transitions, offering new hope for hormonal and emotional support.
Role Reversal: Growing Number of Children Acting as Caregivers for Elderly Family Members
Millions of children in the U.S. are now caregivers for elderly family members, a trend that may worsen with policy changes reducing home care services, impacting their health and education. Learn more about this growing issue and efforts to support young caregivers.
Study Shows Psilocybin Outperforms Traditional Antidepressants in Preserving Emotional Response to Music in Depressed Patients
Recent research reveals that psilocybin enhances emotional responsiveness to music in depressed patients, outperforming traditional antidepressants like escitalopram by preserving emotional engagement and neural responses. Discover how this psychedelic compound could transform depression treatment.